HNB
AGIO icon

Huntington National Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Huntington National Bank’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-425
Closed -$20K – 1513
2019
Q4 		$20K Buy
+425
New +$16.1K ﹤0.01% 1241

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Huntington National Bank's AGIO Position: Q1 2020 in Review

Huntington National Bank sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 425 shares — an estimated $20K sold.

Huntington National Bank first reported a position in AGIO in Q4 2019 and held it in 1 quarter. The position peaked at $20K in Q4 2019. 198 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

  • Huntington National Bank reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Huntington National Bank sold 425 Agios Pharmaceuticals shares in Q1 2020, an estimated $20K.
  • Huntington National Bank first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Huntington National Bank's Agios Pharmaceuticals position peaked at $20K in Q4 2019.
  • 198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Huntington National Bank's 13F filing for Q1 2020, filed 27 Apr 2020.